Amgen Announces Webcast Of 2020 Second Quarter Financial Results

Rhea-AI Summary

Amgen (NASDAQ:AMGN) will release its second quarter financial results on July 28, 2020, after the U.S. markets close. A conference call will take place at 2:00 p.m. PT, featuring insights from CEO Robert A. Bradway. The call will be accessible via a live audio webcast for the media, investors, and public, with an archived version available for 90 days. Amgen continues to focus on innovative therapeutics for serious illnesses, emphasizing high unmet medical needs, and has established itself as a leading biotechnology company since 1980.

THOUSAND OAKS, Calif., July 23, 2020 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its second quarter financial results on Tuesday, July 28, 2020, after the close of the U.S. financial markets. The announcement will be followed by a conference call with the investment community at 2:00 p.m. PT. Participating in the call from Amgen will be Robert A. Bradway, chairman and chief executive officer, and other members of Amgen's senior management team.

Live audio of the conference call will be simultaneously broadcast over the internet and will be available to members of the news media, investors and the general public.

The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.

About Amgen
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential. 

For more information, visit -1%26h%3D241676022%26u%3Dhttp%253A%252F%252Fwww.amgen.com%252F%26a%3Dwww.amgen.com&a=www.amgen.com" rel="nofollow">www.amgen.com and follow us on -1%26h%3D1419808201%26u%3Dhttp%253A%252F%252Fwww.twitter.com%252Famgen%26a%3Dwww.twitter.com%252Famgen&a=www.twitter.com%2Famgen" rel="nofollow">www.twitter.com/amgen.

CONTACT: Amgen, Thousand Oaks
Megan Fox, 805-447-1423 (media)
Trish Rowland, 805-447-5631 (media)
Arvind Sood, 805-447-1060 (investors) 

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/amgen-announces-webcast-of-2020-second-quarter-financial-results-301099104.html

SOURCE Amgen

FAQ

When will Amgen report its Q2 financial results in 2020?

Amgen will report its Q2 financial results on July 28, 2020.

What time is the Amgen conference call for Q2 2020 results?

The Amgen conference call for Q2 2020 results is scheduled for 2:00 p.m. PT.

Where can I listen to the Amgen Q2 2020 financial results webcast?

The Amgen Q2 2020 financial results webcast can be accessed on Amgen's website.

Who will participate in the Amgen Q2 2020 conference call?

CEO Robert A. Bradway and other senior management will participate in the conference call.